The effect of levosimendan in a patients with postinfarction ventricular septal defect
Abstract
SUMMARY
This paper reports the clinic course of a patient with postinfarction ventricular septal defect (VSD). At the period to surgery, the patient received levosimendan for cardio-protection. During the levosimendan infusion, the hemodynamics of the patient worsened. The impairment of hemodynamics and mortality of the patient might be responded to the increase of the amount of left to right shunt, which had possibly occurred due to levosimendan treatment.
Keywords: Levosimendan, acute myocardial infarction, ventricular septal defect, shunt
ÖZET
Bu yazı, akut miyokard infarktüsü sonrası ventriküler septal defekt (VSD) gelişen birhastanın klinik seyrini içermektedir. Cerrahiyi bekleme sürecinde, hastaya kardiyak koruma amacıyla levosimendan infüzyonu başlandı. İnfüzyon esnasında hastanın hemodinamisi kötüleşti. Hemodinamideki bozulmanın, levosimendan tedavisine sekonder soldan sağa şant miktarının artışına bağlı olabileceği düşünüldü.
Anahtar sözcükler: Levosimendan, akut miyokard infarktüsü, ventriküler septal defekt, şant
Keywords
References
- Pohjola-Sintonen S, Muller JE, Stone PH. Ventricular septal and free wall rupture complicating acute myocardial infarction: Expe- rience in the Multicenter Investiga- tion of Limitation of Infarct Size. Am Heart J 1989; 117: 809-18.
- Van de Werf F, Bax J, Betriu A. Management of acute myocardial infarction in patients presenting with persistent ST-segment eleva- tion: The Task Force on the Man- agement of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-45.
- Menon V, Webb JG, Hillis LD. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: A report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000; 36: 1110-6.
- Maltais S, Ibrahim R, Basmadjian AJ. Postinfarction ventricular sep- tal defects: Towards a new treat- ment algorithm? Ann Thorac Surg 2009; 87: 687-92.
- Landoni G, Mizzi A, Biondi- Zoccai G. Reducing mortality in cardiac mendan: A meta-analysis of ran- domized controlled trials. J Cardi- othorac Vasc Anesth 2010; 24: 51- 7. levosi
- Moore CA, Nygaard TW, Kaiser DL. Postinfarction ventricular sep- tal rupture: the importance of loca- tion of infarction and right ven- tricular function in determining survival. Circulation 1986; 74: 45- 55.
- Mebazaa A, Nieminen MS, Packer M. Levosimendan vs dobutamine for patients with acute decompen- sated heart failure: The SURVIVE Randomized Trial. JAMA 2007; 297: 1883-91.
- Boucek MM, Chang R, Synhorst DP. Hemodynamic consequences of inotropic support with digoxin or amrinone in lambs with ventric- ular septal defect. Pediatr Res 1985; 19: 887-91.
Details
Primary Language
English
Subjects
-
Journal Section
-
Publication Date
March 27, 2015
Submission Date
November 4, 2014
Acceptance Date
-
Published in Issue
Year 1970 Volume: 37 Number: 1